Melanocortin 1 receptor: structure, function, and regulation

EM Wolf Horrell, MC Boulanger, JA D'Orazio - Frontiers in genetics, 2016 - frontiersin.org
The melanocortin 1 receptor (MC1R) is a melanocytic Gs protein coupled receptor that
regulates skin pigmentation, UV responses, and melanoma risk. It is a highly polymorphic …

Complex pharmacology of free fatty acid receptors

G Milligan, B Shimpukade, T Ulven… - Chemical …, 2017 - ACS Publications
G protein-coupled receptors (GPCRs) are historically the most successful family of drug
targets. In recent times it has become clear that the pharmacology of these receptors is far …

[图书][B] As Bases Farmacológicas da Terapêutica de Goodman e Gilman-13

LL Brunton, R Hilal-Dandan, BC Knollmann - 2018 - books.google.com
A bíblia azul da farmacologia–assim tem sido mundialmente chamado este clássico
acadêmico desde o lançamento de sua 1ª edição, em 1941. A nova edição de Goodman & …

Making sense of pharmacology: inverse agonism and functional selectivity

KA Berg, WP Clarke - International Journal of …, 2018 - academic.oup.com
Constitutive receptor activity/inverse agonism and functional selectivity/biased agonism are
2 concepts in contemporary pharmacology that have major implications for the use of drugs …

[HTML][HTML] An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice

MS Salahudeen, PS Nishtala - Saudi Pharmaceutical Journal, 2017 - Elsevier
The study of the magnitude and variation of drug response is defined as pharmacodynamics
(PDs). PD models examine plasma concentration and effect relationship. It can predict the …

Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation

LM Mehlmann - Reproduction, 2005 - rep.bioscientifica.com
Mammalian oocytes grow and undergo meiosis within ovarian follicles. Oocytes are arrested
at the first meiotic prophase, held in meiotic arrest by the surrounding follicle cells until a …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

F Teixeira-Clerc, B Julien, P Grenard, JT Van Nhieu… - Nature medicine, 2006 - nature.com
Hepatic fibrosis, the common response associated with chronic liver diseases, ultimately
leads to cirrhosis, a major public health problem worldwide. We recently showed that …

CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

S Jähnichen, C Blanchetot… - Proceedings of the …, 2010 - National Acad Sciences
The important family of G protein-coupled receptors has so far not been targeted very
successfully with conventional monoclonal antibodies. Here we report the isolation and …

[PDF][PDF] Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice

A Louvet, F Teixeira‐Clerc, MN Chobert… - …, 2011 - Wiley Online Library
Activation of Kupffer cells plays a central role in the pathogenesis of alcoholic liver disease.
Because cannabinoid CB2 receptors (CB2) display potent anti‐inflammatory properties, we …